Tissue transglutaminase: A possible role in neurodegenerative diseases

Progress in Neurobiology

Volumn 61, Issue 5, 2000, Pages 439-463

  Lesort, Mathieu ^a   Tucholski, Janusz ^a   Miller, Michael L ^a   Johnson, Gail V W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ALZHEIMER DISEASE; APOPTOSIS; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; GTP-BINDING PROTEINS; HUMANS; NEURODEGENERATIVE DISEASES; TRANSGLUTAMINASES;

EID: 0034257067     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00052-0     Document Type: Review

References (235)

1. Achyuthan K.E., Greenberg C.S. Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J. Biol. Chem. 262:1987;1901-1906.
2. Aeschlimann D., Kaupp O., Paulsson M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J. Cell. Biol. 129:1995;881-892.
3. Aeschlimann D., Koeller M.K., Allen-Hoffmann B.L., Mosher D.F. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription-polymerase chain reaction with degenerate primers. J. Biol. Chem. 273:1998;3452-3460.
4. Aeschlimann D., Mosher D., Paulsson M. Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Semin. Thromb. Hemost. 22:1996;437-443.
5. Aeschlimann D., Paulsson M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J. Biol. Chem. 266:1991;15308-15317.
6. Aeschlimann D., Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb. Haemost. 71:1994;402-415.
7. Albin R.L., Greenamyre J.T. Alternative excitotoxic hypotheses. Neurology. 42:1992;733-738.
8. Ando M., Kunii S., Tatematsu T., Nagata Y. Selective alterations in transglutaminase activity of rat superior cervical ganglia in response to neurotransmitters, high potassium and sialic acid-containing compounds. Brain Res. 604:1993;64-68.
9. Appelt D.M., Balin B.J. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures. Brain Res. 745:1997;21-31.
10. Appelt D.M., Kopen G.C., Boyne L.J., Balin B.J. Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease. J. Histochem. Cytochem. 44:1996;1421-1427.
11. Ashton A.C., Li Y., Doussau F., Weller U., Dougan G., Poulain B., Dolly J.O. Tetanus toxin inhibits neuroexocytosis even when its Zn(2+)-dependent protease activity is removed. J. Biol. Chem. 270:1995;31386-31390.
12. Baek K.J., Das T., Gray C.D., Desai S., Hwang K.C., Gacchui R., Ludwig M., Im M.J. A 50 kDa protein modulates guanine nucleotide binding of transglutaminase II. Biochemistry. 35:1996;2651-2657.
13. Baek K.J., Kwon N.S., Lee H.S., Kim M.S., Muralidhar P., Im M.J. Oxytocin receptor couples to the 80 kDa Gh alpha family protein in human myometrium. Biochem. J. 315:1996;739-744.
14. Baeuerle P.A. The inducible transcription activator NF-kappaB: regulation by distinct protein subunits. Biochim. Biophys. Acta. 1072:1991;63-80.
15. Ballestar E., Abad C., Franco L. Core histones are glutaminyl substrates for tissue transglutaminase. J. Biol. Chem. 271:1996;18817-18824.
16. Beal M.F. Huntington's disease, energy, and excitotoxicity. Neurobiol. Aging. 15:1994;275-276.
17. Beal M.F. Mitochondria, free radicals, and neurodegeneration. Current Opin. Neurobiol. 6:1996;661-666.
18. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta. 1366:1998;211-223.
19. Beal M.F., Hyman B.T., Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? (see comments). Trends Neurosci. 16:1993;125-131.
20. Beninati S., Piacentini M., Cocuzzi E.T., Autuori F., Folk J.E. Covalent incorporation of polyamines as gamma-glutamyl derivatives into CHO cell protein. Biochim. Biophys. Acta. 952:1988;325-333.
21. Berstein G., Blank J.L., Smrcka A.V., Higashijima T., Sternweis P.C., Exton J.H., Ross E.M. Reconstitution of agonist-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis using purified m1 muscarinic receptor, Gq/11, and phospholipase C-beta 1. J. Biol. Chem. 267:1992;8081-8088.
22. Birckbichler P.J., Patterson M.K. Jr. Cellular transglutaminase, growth, and transformation. Ann. NY Acad. Sci. 312:1978;354-365.
23. Blass J.P., Baker A.C., Ko L., Black R.S. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47:1990;864-869.
24. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M., Bird E.D., Beal M.F. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41:1997;646-653.
25. Burke J.R., Enghild J.J., Martin M.E., Jou Y.S., Myers R.M., Roses A.D., Vance J.M., Strittmatter W.J. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH (see comments). Nature Med. 2:1996;347-350.
26. Byrd J.C., Lichti U. Two types of transglutaminase in the PC12 pheochromocytoma cell line. Stimulation by sodium butyrate. J. Biol. Chem. 262:1987;11699-11705.
27. Cariello L., de Cristofaro T., Zanetti L., Cuomo T., Di Maio L., Campanella G., Rinaldi S., Zanetti P., Di Lauro R., Varrone S. Transglutaminase activity is related to CAG repeat length in patients with Huntington's disease. Hum. Genet. 98:1996;633-635.
28. Cariello L., Velasco P.T., Wilson J., Parameswaran K.N., Karush F., Lorand L. Probing the transglutaminase-mediated, posttranslational modification of proteins during development. Biochemistry. 29:1990;5103-5108.
29. Carmel G., Mager E.M., Binder L.I., Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271:1996;32789-32795.
30. Chakraborty G., Leach T., Zanakis M.F., Sturman J.A., Ingoglia N.A. Posttranslational protein modification by polyamines in intact and regenerating nerves. J. Neurochem. 48:1987;669-675.
31. Chan P.H., Fishman R.A. Transient formation of superoxide radicals in polyunsaturated fatty acid-induced brain swelling. J. Neurochem. 35:1980;1004-1007.
32. Chang S.K., Chung S.I. Cellular transglutaminase. The particulate-associated transglutaminase from chondrosarcoma and liver: partial purification and characterization. J. Biol. Chem. 261:1986;8112-8121.
33. Chen S., Lin F., Iismaa S., Lee K.N., Birckbichler P.J., Graham R.M. Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J. Biol. Chem. 271:1996;32385-32391.
34. Chowdhury Z.A., Barsigian C., Chalupowicz G.D., Bach T.L., Garcia-Manero G., Martinez J. Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells. Exp. Cell. Res. 231:1997;38-49.
35. Clement S., Velasco P.T., Murthy S.N., Wilson J.H., Lukas T.J., Goldman R.D., Lorand L. The intermediate filament protein, vimentin, in the lens is a target for cross-linking by transglutaminase. J. Biol. Chem. 273:1998;7604-7609.
36. Cleveland D.W., Hwo S.Y., Kirschner M.W. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol. 116:1977;227-247.
37. Coffield J.A., Considine R.V., Jeyapaul J., Maksymowych A.B., Zhang R.D., Simpson L.L. The role of transglutaminase in the mechanism of action of tetanus toxin. J. Biol. Chem. 269:1994;24454-24458.
38. Cooper A.J., Sheu K.F., Burke J.R., Onodera O., Strittmatter W.J., Roses A.D., Blass J.P. Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG/poly-Q neurodegenerative diseases? J. Neurochem. 69:1997;431-434.
39. Cooper A.J., Sheu K.F., Burke J.R., Strittmatter W.J., Gentile V., Peluso G., Blass J.P. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability. J. Neurochem. 72:1999;889-899.
40. Cooper A.J.L., Sheu K.R., Burke J.R., Onodera O., Strittmatter W.J., Roses A.D., Blass J.P. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc. Natl. Acad. Sci. USA. 94:1997;12604-12609.
41. Cordella-Miele E., Miele L., Beninati S., Mukherjee A.B. Transglutaminase-catalyzed incorporation of polyamines into phospholipase A2. J. Biochem. 113:1993;164-173.
42. Cotman C.W., Anderson A.J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:1995;19-45.
43. Cotman C.W., Whittemore E.R., Watt J.A., Anderson A.J., Loo D.T. Possible role of apoptosis in Alzheimer's disease. Ann. NY Acad. Sci. 747:1994;36-49.
44. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
45. David G., Abbas N., Stevanin G., Durr A., Yvert G., Cancel G., Weber C., Imbert G., Saudou F., Antoniou E., Drabkin H., Gemmill R., Giunti P., Benomar A., Wood N., Ruberg M., Agid Y., Mandel J.L., Brice A. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genet. 17:1997;65-70.
46. Davies P.J., Murtaugh M.P., Moore W.T. Jr, Johnson G.S., Lucas D. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. J. Biol. Chem. 260:1985;5166-5174.
47. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 90:1997;537-548.
48. Delacourte A., Defossez A. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J. Neurol. Sci. 76:1986;173-186.
49. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 277:1997;1990-1993.
50. Driscoll H.K., Adkins C.D., Chertow T.E., Cordle M.B., Matthews K.A., Chertow B.S. Vitamin A stimulation of insulin secretion: effects on transglutaminase mRNA and activity using rat islets and insulin-secreting cells. Pancreas. 15:1997;69-77.
51. Dubbink H.J., Verkaik N.S., Faber P.W., Trapman J., Schroder F.H., Romijn J.C. Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase. Biochem. J. 315:1996;901-908.
52. Dudek S.M., Johnson G.V. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J. Neurochem. 61:1993;1159-1162.
53. Dudek S.M., Johnson G.V. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Brain Res. 651:1994;129-133.
54. Eitan S., Schwartz M. A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science. 261:1993;106-108.
55. Eitan S., Solomon A., Lavie V., Yoles E., Hirschberg D.L., Belkin M., Schwartz M. Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science. 264:1994;1764-1768.
56. Facchiano F., Benfenati F., Valtorta F., Luini A. Covalent modification of synapsin I by a tetanus toxin-activated transglutaminase. J. Biol. Chem. 268:1993;4588-4591.
57. Facchiano F., Luini A. Tetanus toxin potently stimulates tissue transglutaminase. A possible mechanism of neurotoxicity. J. Biol. Chem. 267:1992;13267-13271.
58. Feng J.F., Gray C.D., Im M.J. Alpha 1B-adrenoceptor interacts with multiple sites of transglutaminase II: characteristics of the interaction in binding and activation. Biochemistry. 38:1999;2224-2232.
59. Feng J.F., Rhee S.G., Im M.J. Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J. Biol. Chem. 271:1996;16451-16454.
60. Fesus L. Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes. Cell. Mol. Neurobiol. 18:1998;683-694.
61. Fields T.A., Casey P.J. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J. 321:1997;561-571.
62. Folk J.E. Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Adv. Enzymol. Relat. Areas Mol. Biol. 54:1983;1-56.
63. Folk J.E., Finlayson J.S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv. Protein Chem. 31:1977;1-133.
64. Folk J.E., Park M.H., Chung S.I., Schrode J., Lester E.P., Cooper H.L. Polyamines as physiological substrates for transglutaminases. J. Biol. Chem. 255:1980;3695-3700.
65. Fraij B.M., Gonzales R.A. A third human tissue transglutaminase homologue as a result of alternative gene transcripts. Biochim. Biophys. Acta. 1306:1996;63-74.
66. Fraij B.M., Gonzales R.A. Organization and structure of the human tissue transglutaminase gene. Biochim. Biophys. Acta. 1354:1997;65-71.
67. Friedrich P., Fesus L., Tarcsa E., Czeh G. Protein cross-linking by transglutaminase induced in long-term potentiation in the Ca1 region of hippocampal slices. Neuroscience. 43:1991;331-334.
68. Fukuda K., Kojiro M., Chiu J.F. Differential regulation of tissue transglutaminase in rat hepatoma cell lines McA-RH7777 and McA-RH8994: relation to growth rate and cell death. J. Cell. Biochem. 54:1994;67-77.
69. Gentile V., Saydak M., Chiocca E.A., Akande O., Birckbichler P.J., Lee K.N., Stein J.P., Davies P.J. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J. Biol. Chem. 266:1991;478-483.
70. Gentile V., Sepe C., Calvani M., Melone M.A., Cotrufo R., Cooper A.J., Blass J.P., Peluso G. Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch. Biochem. Biophys. 352:1998;314-321.
71. Gentile V., Thomazy V., Piacentini M., Fesus L., Davies P.J. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J. Cell. Biol. 119:1992;463-474.
72. George M.D., Vollberg T.M., Floyd E.E., Stein J.P., Jetten A.M. Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. J. Biol. Chem. 265:1990;11098-11104.
73. Gilad G.M., Varon L.E. Transglutaminase activity in rat brain: characterization, distribution, and changes with age. J. Neurochem. 45:1985;1522-1526.
74. Gilad G.M., Varon L.E., Gilad V.H. Calcium-dependent transglutaminase of rat sympathetic ganglion in development and after nerve injury. J. Neurochem. 44:1985;1385-1390.
75. Gilman A.G. G proteins: transducers of receptor-generated signals. Ann. Rev. Biochem. 56:1987;615-649.
76. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992;159-168.
77. Goldberg Y.P., McMurray C.T., Zeisler J., Almqvist E., Sillence D., Richards F., Gacy A.M., Buchanan J., Telenius H., Hayden M.R. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum. Mol. Genet. 4:1995;1911-1928.
78. Goldman R.D., Khuon S., Chou Y.H., Opal P., Steinert P.M. The function of intermediate filaments in cell shape and cytoskeletal integrity. J. Cell. Biol. 134:1996;971-983.
79. Gorza L., Menabo R., Di Lisa F., Vitadello M. Troponin T cross-linking in human apoptotic cardiomyocytes. Am. J. Pathol. 150:1997;2087-2097.
80. Grant F.J., Taylor D.A., Sheppard P.O., Mathewes S.L., Lint W., Vanaja E., Bishop P.D., O'Hara P.J. Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library. Biochem. Biophys. Res. Commun. 203:1994;1117-1123.
81. Green H. Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism (letter). Cell. 74:1993;955-956.
82. Greenberg C.S., Birckbichler P.J., Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5:1991;3071-3077.
83. Groenen P.J., Seccia M., Smulders R.H., Gravela E., Cheeseman K.H., Bloemendal H., de Jong W.W. Exposure of beta H-crystallin to hydroxyl radicals enhances the transglutaminase-susceptibility of its existing amine-donor and amine-acceptor sites. Biochem. J. 295:1993;399-404.
84. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport. 8:1996;379-383.
85. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., Li X.J. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19:1999;2522-2534.
86. Guttmann R.P., Erickson A.C., Johnson G.V. Tau self-association: stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state. J. Neurochem. 64:1995;1209-1215.
87. Guttmann R.P., Johnson G.V. Oxidative stress inhibits calpain activity in situ. J. Biol. Chem. 273:1998;13331-13338.
88. Guttmann R.P., Johnson G.V.W. Calpain-mediated proteolysis of neuronal structural proteins. Wang K.K.W., Yuen P.-W. Calpain: Pharmacology and Toxicology of Calcium-Dependent Protease. 1999;229-249 Taylor and Francis, Philadelphia.
89. Hand D., Bungay P.J., Elliott B.M., Griffin M. Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein. Biosci. Rep. 5:1985;1079-1086.
90. Hand D., Campoy F.J., Clark S., Fisher A., Haynes L.W. Activity and distribution of tissue transglutaminase in association with nerve-muscle synapses. J. Neurochem. 61:1993;1064-1072.
91. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
92. Hilf G., Kupprion C., Wieland T., Jakobs K.H. Dissociation of guanosine 5′-[gamma-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes. Regulation by nucleotides and muscarinic acetylcholine receptors. Eur. J. Biochem. 204:1992;725-731.
93. Ho G.J., Gregory E.J., Smirnova I.V., Zoubine M.N., Festoff B.W. Cross-linking of beta-amyloid protein precursor catalyzed by tissue transglutaminase. FEBS Lett. 349:1994;151-154.
94. Ho K.C., Quarmby V.E., French F.S., Wilson E.M. Molecular cloning of rat prostate transglutaminase complementary DNA. The major androgen-regulated protein DP1 of rat dorsal prostate and coagulating gland. J. Biol. Chem. 267:1992;12660-12667.
95. Hwang K.C., Gray C.D., Sivasubramanian N., Im M.J. Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C. J. Biol. Chem. 270:1995;27058-27062.
96. Hwang K.C., Gray C.D., Sweet W.E., Moravec C.S., Im M.J. Alpha 1-adrenergic receptor coupling with Gh in the failing human heart (see comments). Circulation. 94:1996;718-726.
97. Igarashi S., Koide R., Shimohata T., Yamada M., Hayashi Y., Takano H., Date H., Oyake M., Sato T., Sato A., Egawa S., Ikeuchi T., Tanaka H., Nakano R., Tanaka K., Hozumi I., Inuzuka T., Takahashi H., Tsuji S. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet. 18:1998;111-117.
98. Iismaa S.E., Chung L., Wu M.J., Teller D.C., Yee V.C., Graham R.M. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP. Biochemistry. 36:1997;11655-11664.
99. Ikeda H., Yamaguchi M., Sugai S., Aze Y., Narumiya S., Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13:1996;196-202.
100. Ikura K., Kita K., Fujita I., Hashimoto H., Kawabata N. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe. Arch. Biochem. Biophys. 356:1998;280-286.
101. Ikura K., Nasu T., Yokota H., Tsuchiya Y., Sasaki R., Chiba H. Amino acid sequence of guinea pig liver transglutaminase from its cDNA sequence. Biochemistry. 27:1988;2898-2905.
102. Ikura K., Takahata K., Sasaki R. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase. FEBS Lett. 326:1993;109-111.
103. Ikura K., Yu C., Nagao M., Sasaki R., Furuyoshi S., Kawabata N. Site-directed mutation in conserved anionic regions of guinea pig liver transglutaminase. Arch. Biochem. Biophys. 318:1995;307-313.
104. Im M.J., Russell M.A., Feng J.F. Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal. 9:1997;477-482.
105. Imbert G., Saudou F., Yvert G., Devys D., Trottier Y., Garnier J.M., Weber C., Mandel J.L., Cancel G., Abbas N., Durr A., Didierjean O., Stevanin G., Agid Y., Brice A. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats (see comments). Nature Genet. 14:1996;285-291.
106. Iwasaki W., Nagata K., Hatanaka H., Inui T., Kimura T., Muramatsu T., Yoshida K., Tasumi M., Inagaki F. Solution structure of midkine, a new heparin-binding growth factor. EMBO J. 16:1997;6936-6946.
107. Jensen P.H., Sorensen E.S., Petersen T.E., Gliemann J., Rasmussen L.K. Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide. Biochem. J. 310:1995;91-94.
108. Johnson G.V., Cox T.M., Lockhart J.P., Zinnerman M.D., Miller M.L., Powers R.E. Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res. 751:1997;323-329.
109. Johnson T.S., Scholfield C.I., Parry J., Griffin M. Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas. Biochem. J. 331:1998;105-112.
110. Kahlem P., Green H., Djian P. Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol. Cell. 1:1998;595-601.
111. Kahlem P., Terre C., Green H., Djian P. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system (see comments). Proc. Natl. Acad. Sci. USA. 93:1996;14580-14585.
112. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
113. Katoh S., Nakagawa N., Yano Y., Satoh K., Kohno H., Ohkubo Y. Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocytes. Biochem. J. 313:1996;305-309.
114. Kim H.C., Idler W.W., Kim I.G., Han J.H., Chung S.I., Steinert P.M. The complete amino acid sequence of the human transglutaminase K enzyme deduced from the nucleic acid sequences of cDNA clones. J. Biol. Chem. 266:1991;536-539.
115. Kim I.G., Lee S.C., Lee J.H., Yang J.M., Chung S.I., Steinert P.M. Structure and organization of the human transglutaminase 3 gene: evolutionary relationship to the transglutaminase family. J. Invest. Dermatol. 103:1994;137-142.
116. Kim M., Lee H.S., LaForet G., McIntyre C., Martin E.J., Chang P., Kim T.W., Williams M., Reddy P.H., Tagle D., Boyce F.M., Won L., Heller A., Aronin N., DiFiglia M. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19:1999;964-973.
117. Kim S.Y., Kim I.G., Chung S.I., Steinert P.M. The structure of the transglutaminase 1 enzyme. Deletion cloning reveals domains that regulate its specific activity and substrate specificity. J. Biol. Chem. 269:1994;27979-27986.
118. Kim S.Y., Grant P., Lee J.H., Pant H.C., Steinert P.M. Differential expression of multiple transglutaminases in human brain: Increased expression and crosslinking by transglutaminases 1 and 2 in Alzheimer's Disease. J. Biol. Chem. 274:1999;30715-30721.
119. Kojima S., Inui T., Muramatsu H., Suzuki Y., Kadomatsu K., Yoshizawa M., Hirose S., Kimura T., Sakakibara S., Muramatsu T. Dimerization of midkine by tissue transglutaminase and its functional implication. J. Biol. Chem. 272:1997;9410-9416.
120. Korner G., Schneider D.E., Purdon M.A., Bjornsson T.D. Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity. Biochem. J. 262:1989;633-641.
121. Korsgren C., Cohen C.M. Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII. Proc. Natl. Acad. Sci. USA. 88:1991;4840-4844.
122. Koshy B., Matilla T., Burright E.N., Merry D.E., Fischbeck K.H., Orr H.T., Zoghbi H.Y. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum. Mol. Genet. 5:1996;1311-1318.
123. Kosik K.S., Joachim C.L., Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 83:1986;4044-4048.
124. Ku C.Y., Qian A., Wen Y., Anwer K., Sanborn B.M. Oxytocin stimulates myometrial guanosine triphosphatase and phospholipase-C activities via coupling to G alpha q/11. Endocrinology. 136:1995;1509-1515.
125. Kwak S.J., Kim S.Y., Kim Y.S., Song K.Y., Kim I.G., Park S.C. Isolation and characterization of brain-specific transglutaminases from rat. Exp. Mol. Med. 30:1998;177-185.
126. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352:1991;77-79.
127. Lai T.S., Achyuthan K.E., Santiago M.A., Greenberg G.S. Carboxyl-terminal truncation of recombinant factor XIII-A chains. Characterization of minimum structural requirement for transglutaminase activity. J. Biol. Chem. 269:1994;24596-24601.
128. Lai T.S., Bielawska A., Peoples K.A., Hannun Y.A., Greenberg C.S. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. J. Biol. Chem. 272:1997;16295-16300.
129. Lai T.S., Slaughter T.F., Koropchak C.M., Haroon Z.A., Greenberg C.S. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J. Biol. Chem. 271:1996;31191-31195.
130. Lai T.S., Slaughter T.F., Peoples K.A., Hettasch J.M., Greenberg C.S. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J. Biol. Chem. 273:1998;1776-1781.
131. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H.M. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropath. 89:1995;35-41.
132. Lavie L., Weinreb O. Age- and strain-related changes in tissue transglutaminase activity in murine macrophages: the effects of inflammation and induction by retinol. Mech. Ageing Develop. 90:1996;129-143.
133. Lee C.H., Park D., Wu D., Rhee S.G., Simon M.I. Members of the Gq alpha subunit gene family activate phospholipase C beta isozymes. J. Biol. Chem. 267:1992;16044-16047.
134. Lee K.N., Arnold S.A., Birckbichler P.J., Patterson M.K. Jr, Fraij B.M., Takeuchi Y., Carter H.A. Site-directed mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. Biochim. Biophys. Acta. 1202:1993;1-6.
135. Lee V.M., Balin B.J., Otvos L. Jr, Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 251:1991;675-678.
136. Lesort M., Attanavanich K., Zhang J., Johnson G.V. Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem. 273:1998;11991-11994.
137. Lesort, M., Chun, W., Johnson, G.V.W., Ferrante, R.J., 1999. Tissue transglutaminase is increased in Huntington's disease brain. J. Neurochem. 73, 2018-2027.
138. Litersky J.M., Johnson G.V. Phosphorylation of tau in situ: inhibition of calcium-dependent proteolysis. J. Neurochem. 65:1995;903-911.
139. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
140. Lorand L. DRPLA aggregation and transglutaminase, revisited (letter). Nature Genet. 20:1998;231.
141. Lorand L., Conrad S.M. Transglutaminases. Mol. Cell. Biochem. 58:1984;9-35.
142. Lu S., Davies P.J.A. Regulation of the expression of the tissue transglutaminase gene by DNA methylation. Proc. Natl. Acad. Sci. USA. 94:1997;4692-4697.
143. Lu S., Saydak M., Gentile V., Stein J.P., Davies P.J. Isolation and characterization of the human tissue transglutaminase gene promoter. J. Biol. Chem. 270:1995;9748-9756.
144. Lue L.F., Brachova L., Civin W.H., Rogers J. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropath Exp. Neurol. 55:1996;1083-1088.
145. Lunkes A., Mandel J.L. Polyglutamines, nuclear inclusions and neurodegeneration (news). Nature Med. 3:1997;1201-1202.
146. Maccioni R.B., Seeds N.W. Transglutaminase and neuronal differentiation. Mol. Cell. Biochem. 69:1986;161-168.
147. Mahoney S.A., Perry M., Seddon A., Bohlen P., Haynes L. Transglutaminase forms midkine homodimers in cerebellar neurons and modulates the neurite-outgrowth response. Biochem. Biophys. Res. Commun. 224:1996;147-152.
148. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
149. Mark R.J., Blanc E.M., Mattson M.P. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol. Neurobiol. 12:1996;211-224.
150. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
151. Mattson, M.P., 1995. Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD. Neurobiol. Aging 16, 447-457, 458-463, discussion.
152. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
153. McGeer E.G., McGeer P.L. The role of the immune system in neurodegenerative disorders. Movement Disorders. 12:1997;855-858.
154. McIntosh L.J., Sapolsky R.M. Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp. Neurol. 141:1996;201-206.
155. Melino G., Piacentini M. 'Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector? (in process citation). FEBS Lett. 430:1998;59-63.
156. Miller C.C., Anderton B.H. Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease. J. Neurochem. 46:1986;1912-1922.
157. Miller M.L., Johnson G.V. Transglutaminase cross-linking of the tau protein. J. Neurochem. 65:1995;1760-1770.
158. Milligan G., Klee W.A. The inhibitory guanine nucleotide-binding protein (Ni) purified from bovine brain is a high affinity GTPase. J. Biol. Chem. 260:1985;2057-2063.
159. Mirza A., Liu S.L., Frizell E., Zhu J., Maddukuri S., Martinez J., Davies P., Schwarting R., Norton P., Zern M.A. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am. J. Physiol. 272:1997;G281-2888.
160. Monsonego A., Mizrahi T., Eitan S., Moalem G., Bardos H., Adany R., Schwartz M. Factor XIII-A as a nerve-associated transglutaminase. FASEB J. 12:1998;1163-1171.
161. Monsonego A., Shani Y., Friedmann I., Paas Y., Eizenberg O., Schwartz M. Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes. J. Biol. Chem. 272:1997;3724-3732. (published erratum appears in J. Biol. Chem. 1997 March 14;272(11):7565).
162. Moore W.T. Jr, Murtaugh M.P., Davies P.J. Retinoic acid-induced expression of tissue transglutaminase in mouse peritoneal macrophages. J. Biol. Chem. 259:1984;12794-12802.
163. Murthy S.N., Wilson J.H., Lukas T.J., Kuret J., Lorand L. Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase. J. Neurochem. 71:1998;2607-2614.
164. Nagafuchi S., Yanagisawa H., Sato K., Shirayama T., Ohsaki E., Bundo M., Takeda T., Tadokoro K., Kondo I., Murayama N. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet. 6:1994;14-18.
165. Nagy L., Saydak M., Shipley N., Lu S., Basilion J.P., Yan Z.H., Syka P., Chandraratna R.A., Stein J.P., Heyman R.A., Davies P.J. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 271:1996;4355-4365.
166. Nakanishi K., Nara K., Hagiwara H., Aoyama Y., Ueno H., Hirose S. Cloning and sequence analysis of cDNA clones for bovine aortic-endothelial-cell transglutaminase. Eur. J. Biochem. 202:1991;15-21.
167. Nakaoka H., Perez D.M., Baek K.J., Das T., Husain A., Misono K., Im M.J., Graham R.M. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 264:1994;1593-1596.
168. Nara K., Nakanishi K., Hagiwara H., Wakita K., Kojima S., Hirose S. Retinol-induced morphological changes of cultured bovine endothelial cells are accompanied by a marked increase in transglutaminase. J. Biol. Chem. 264:1989;19308-19312.
169. Nemes Z. Jr, Adany R., Balazs M., Boross P., Fesus L. Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J. Biol. Chem. 272:1997;20577-20583.
170. Ohashi H., Itoh Y., Birckbichler P.J., Takeuchi Y. Purification and characterization of rat brain transglutaminase. J. Biochem. (Tokyo). 118:1995;1271-1278.
171. Oliverio S., Amendola A., Di Sano F., Farrace M.G., Fesus L., Nemes Z., Piredda L., Spinedi A., Piacentini M. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol. Cell. Biol. 17:1997;6040-6048.
172. Ordway J.M., Tallaksen-Greene S., Gutekunst C.A., Bernstein E.M., Cearley J.A., Wiener H.W., Dure L.S.T., Lindsey R., Hersch S.M., Jope R.S., Albin R.L., Detloff P.J. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 91:1997;753-763.
173. Orr H.T., Chung M.Y., Banfi S., Kwiatkowski T.J. Jr, Servadio A., Beaudet A.L., McCall A.E., Duvick L.A., Ranum L.P., Zoghbi H.Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4:1993;221-226.
174. Pacheco, M.A., Jope, R.S., 1999. Modulation of carbachol-stimulated AKP-1 DNA binding by bipolar therapeutic agents in human neuroblastoma SH-SY5Y cells. Brain Res 72, 138-146.
175. Parameswaran K.N., Cheng X.F., Chen E.C., Velasco P.T., Wilson J.H., Lorand L. Hydrolysis of gamma: epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIII-A. J. Biol. Chem. 272:1997;10311-10317.
176. Park E.S., Won J.H., Han K.J., Suh P.G., Ryu S.H., Lee H.S., Yun H.Y., Kwon N.S., Baek K.J. Phospholipase C-delta1 and oxytocin receptor signalling: evidence of its role as an effector. Biochem. J. 331:1998;283-289.
177. Peng X., Zhang Y., Zhang H., Graner S., Williams J.F., Levitt M.L., Lokshin A. Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett. 446:1999;35-39.
178. Perry M.J., Haynes L.W. Localization and activity of transglutaminase, a retinoid-inducible protein, in developing rat spinal cord. Int. J. Dev. Neurosci. 11:1993;325-337.
179. Perry M.J., Mahoney S.A., Haynes L.W. Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking. Neuroscience. 65:1995;1063-1076.
180. Perutz M. Polar zippers: their role in human disease. Protein Science. 3:1994;1629-1637.
181. Perutz M.F., Johnson T., Suzuki M., Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 91:1994;5355-5358.
182. Peterson C., Goldman J.E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA. 83:1986;2758-2762.
183. Phillips M.A., Stewart B.E., Qin Q., Chakravarty R., Floyd E.E., Jetten A.M., Rice R.H. Primary structure of keratinocyte transglutaminase. Proc. Natl. Acad. Sci. USA. 87:1990;9333-9337.
184. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J.L., Melino E. Phenotype-specific 'tissue' transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer. 52:1992;271-278.
185. Piacentini M., Ceru M.P., Dini L., Di Rao M., Piredda L., Thomazy V., Davies P.J., Fesus L. In vivo and in vitro induction of 'tissue' transglutaminase in rat hepatocytes by retinoic acid. Biochim. Biophys. Acta. 1135:1992;171-179.
186. Piacentini M., Fesus L., Sartori C., Ceru M.P. Retinoic acid-induced modulation of rat liver transglutaminase and total polyamines in vivo. Biochem. J. 253:1988;33-38.
187. Piacentini M., Martinet N., Beninati S., Folk J.E. Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J. Biol. Chem. 263:1988;3790-3794.
188. Piacentini M., Melino G. Role of tissue transglutaminase in neuroblastoma cells undergoing apoptosis. Prog. Clin. Biol. Res. 385:1994;123-129.
189. Piacentini M., Piredda L., Starace D.T., Annicchiarico-Petruzzelli M., Mattei M., Oliverio S., Farrace M.G., Melino G. Differential growth of N- and S-type human neuroblastoma cells xenografted into scid mice. correlation with apoptosis. J. Pathol. 180:1996;415-422.
190. Piredda L., Farrace M.G., Lo Bello M., Malorni W., Melino G., Petruzzelli R., Piacentini M. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 13:1999;355-364.
191. Pulst S.M., Nechiporuk A., Nechiporuk T., Gispert S., Chen X.N., Lopes-Cendes I., Pearlman S., Starkman S., Orozco-Diaz G., Lunkes A., DeJong P., Rouleau G.A., Auburger G., Korenberg J.R., Figueroa C., Sahba S. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 (see comments). Nature Genet. 14:1996;269-276.
192. Rasmussen L.K., Sorensen E.S., Petersen T.E., Gliemann J., Jensen P.H. Identification of glutamine and lysine residues in Alzeimer amyloid beta A4 peptide responsible fn transglutaminase-catalyzed homopolymerization and cross-linking to alpha 2M receptor. FEBS Lett. 338:1994;161-166.
193. Ratan R.R., Murphy T.H., Baraban J.M. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:1994;376-379.
194. Rens-Domiano S., Hamm H.E. Structural and functional relationships of heterotrimeric G-proteins. FASEB J. 9:1995;1059-1066.
195. Rhee S.G., Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272:1997;15045-15048.
196. Riepe M.W., Hori N., Ludolph A.C., Carpenter D.O. Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience. 64:1995;91-97.
197. Ritter S.J., Davies P.J. Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 273:1998;12798-12806.
198. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
199. Rogers J., Webster S., Lue L.F., Brachova L., Civin W.H., Emmerling M., Shivers B., Walker D., McGeer P. Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging. 17:1996;681-686.
200. Ross C.A. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron. 19:1997;1147-1150.
201. Rybicki A.C., Schwartz R.S., Qiu J.J., Gilman J.G. Molecular cloning of mouse erythrocyte protein 4.2: a membrane protein with strong homology with the transglutaminase supergene family. Mamm. Genome. 5:1994;438-445.
202. Sanpei K., Takano H., Igarashi S., Sato T., Oyake M., Sasaki H., Wakisaka A., Tashiro K., Ishida Y., Ikeuchi T., Koide R., Saito M., Sato A., Tanaka T., Hanyu S., Takiyama Y., Nishizawa M., Shimizu N., Nomura Y., Segawa M., Iwabuchi K., Eguchi I., Tanaka H., Takahashi H., Tsuji S. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT (see comments). Nature Genet. 14:1996;277-284.
203. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66.
204. Selkoe D.J., Abraham C., Ihara Y. Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc. Natl. Acad. Sci. USA. 79:1982;6070-6074.
205. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease (see comments). Nature. 375:1995;754-760.
206. Singh U.S., Erickson J.W., Cerione R.A. Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry. 34:1995;15863-15871.
207. Slife C.W., Dorsett M.D., Bouquett G.T., Register A., Taylor E., Conroy S. Subcellular localization of a membrane-associated transglutaminase activity in rat liver. Arch. Biochem. Biophys. 241:1985;329-336.
208. Smale G., Nichols N.R., Brady D.R., Finch C.E., Horton W.E. Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133:1995;225-230.
209. Small K., Feng J.F., Lorenz J., Donnelly E.T., Yu A., Im M.J., Dorn G.W., Liggett S.B. Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J. Biol. Chem. 274:1999;21291-21296.
210. 2+ and nucleotides. Biochem. J. 313:1996;803-808.
211. Su J.H., Anderson A.J., Cummings B.J., Cotman C.W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 5:1994;2529-2533.
212. Sutherland M.K., Wong L., Somerville M.J., Yoong L.K., Bergeron C., Parmentier M., McLachlan D.R. Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. Brain Res. Mol. Brain Res. 18:1993;32-42.
213. Suto N., Ikura K., Sasaki R. Expression induced by interleukin-6 of tissue-type transglutaminase in human hepatoblastoma HepG2 cells. J. Biol. Chem. 268:1993;7469-7473.
214. Suto N., Ikura K., Shinagawa R., Sasaki R. Identification of promoter region of guinea pig liver transglutaminase gene. Biochim. Biophys. Acta. 1172:1993;319-322.
215. Takeuchi Y., Birckbichler P.J., Patterson M.K. Jr, Lee K.N. Putative nucleotide binding sites of guinea pig liver transglutaminase. FEBS Lett. 307:1992;177-180.
216. Tetzlaff W., Gilad V.H., Leonard C., Bisby M.A., Gilad G.M. Retrograde changes in transglutaminase activity after peripheral nerve injuries. Brain Res. 445:1988;142-146.
217. The Huntington's Disease Collaborative Research Group, 1993. A novel gene containinga trinucleotide repeat that is expanded and unstable on Huntington's Disease chromosomes. Cell 72, 971-983.
218. Trottier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E.C., Mandel J.L. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form (see comments). Nature Genet. 10:1995;104-110.
219. Tucholski, J., Kuret, J., Johnson, G.V.W., 1999. Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J. Neurochem. 73, 1871-1880.
220. Upchurch H.F., Conway E., Patterson M.K. Jr, Maxwell M.D. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J. Cell. Physiol. 149:1991;375-382.
221. Verma A.K., Shoemaker A., Simsiman R., Denning M., Zachman R.D. Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed a vitamin A deficient diet. J. Nutr. 122:1992;2144-2152.
222. Vezza R., Habib A., FitzGerald G.A. Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh. J. Biol. Chem. 274:1999;12774-12779.
223. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 57:1998;369-384.
224. Weraarchakul-Boonmark N., Jeong J.M., Murthy S.N., Engel J.D., Lorand L. Cloning and expression of chicken erythrocyte transglutaminase. Proc. Natl. Acad. Sci. USA. 89:1992;9804-9808.
225. Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 85:1988;4506-4510.
226. Wisniewski T., Ghiso J., Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179:1991;1247-1254. (published erratum appears in Biochem. Biophys. Res. Commun. 1991 November 14;180(3):1528).
227. Wolozin B., Iwasaki K., Vito P., Ganjei J.K., Lacana E., Sunderland T., Zhao B., Kusiak J.W., Wasco W., D'Adamio L. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-1713.
228. Wolozin B.L., Pruchnicki A., Dickson D.W., Davies P. A neuronal antigen in the brains of Alzheimer patients. Science. 232:1986;648-650.
229. Yee V.C., Le Trong I., Bishop P.D., Pedersen L.C., Stenkamp R.E., Teller D.C. Structure and function studies of factor XIII-A by X-ray crystallography. Semin. Thromb. Hemost. 22:1996;377-384.
230. Yee V.C., Pedersen L.C., Le Trong I., Bishop P.D., Stenkamp R.E., Teller D.C. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc. Natl. Acad. Sci. USA. 91:1994;7296-7300.
231. Zhang J., Guttmann R.P., Johnson G.V. Tissue transglutaminase is an in situ substrate of calpain: regulation of activity. J. Neurochem. 71:1998;240-247.
232. Zhang J., Lesort M., Guttmann R.P., Johnson G.V. Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J. Biol. Chem. 273:1998;2288-2295.
233. Zhang, J., Tucholski, J., Lesort, M., Jope, R.S., Johnson, G.V.W., 1999. Novel bimodal effects of the G protein tissue transglutaminase on adrenoreceptor signaling. Biochem. J 343, 541-549.
234. Zhang W., Johnson B.R., Suri D.E., Martinez J., Bjornsson T.D. Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques. Acta Neuropathol. 96:1998;395-400.
235. Zhuchenko O., Bailey J., Bonnen P., Ashizawa T., Stockton D.W., Amos C., Dobyns W.B., Subramony S.H., Zoghbi H.Y., Lee C.C. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nature Genet. 15:1997;62-69.